1. Foxman B, Barlow R, D’Arcy H, et al. Urinary tract infection: self-reported incidence and associated costs. Ann Epidemiol. 2000;10:509–15. [PubMed] [Google Scholar]
2. Foxman B. Recurring urinary tract infection: incidence and risk factors. Am J Public Health. 1990;80:331–3. [PMC free article] [PubMed] [Google Scholar]
3. Epp A, Larochelle A, Lovatsis D, et al. Recurrent urinary tract infection. J Obstet Gynaecol Can. 2010;32:1082–101. [PubMed] [Google Scholar]
4. Grabe M, Bjerklund-Johansen TE, Botto H, et al. European Association of Urology: Guidelines on Urological Infections. 2010 [Google Scholar]
5. Segal AJ, Amis ES, Jr, Bigongiari LR, et al. Recurrent lower urinary tract infections in women. American College of Radiology. ACR Appropriateness Criteria. Radiology. 2000;215:671–6. [PubMed] [Google Scholar]
6. ACOG Practice Bulletin No. 91: Treatment of urinary tract infections in nonpregnant women. Obstet Gynecol. 2008;111:785–94. [PubMed] [Google Scholar]
7. Echols RM, Tosiello RL, Haverstock DC, et al. Demographic, clinical, and treatment parameters influencing the outcome of acute cystitis. Clin Infect Dis. 1999;29:113–9. [PubMed] [Google Scholar]
8. Hooton TM. Recurrent urinary tract infection in women. Int J Antimicrob Agents. 2001;17:259–68. [PubMed] [Google Scholar]
9. Hooton TM. Recurrent urinary tract infection in women. UpToDate. 2011. http://www.uptodate.com/contents/recurrent-urinary-tract-infection-in-women. Accessed September 21, 2011. [PubMed]
10. Campbell MF, Wein AJ, Kavoussi LR. Campbell-Walsh Urology. 9th edition. Philadelphia: W.B. Saunders; 2007. [Google Scholar]
11. Bent S, Nallamothu BK, Simel DL, et al. Does this woman have an acute uncomplicated urinary tract infection? JAMA. 2002;287:2701–10. [PubMed] [Google Scholar]
12. Giesen LG, Cousins G, Dimitrov BD, et al. Predicting acute uncomplicated urinary tract infection in women: a systematic review of the diagnostic accuracy of symptoms and signs. BMC Fam Pract. 2010;11:78. [PMC free article] [PubMed] [Google Scholar]
13. Dielubanza EJ, Schaeffer AJ. Urinary tract infections in women. Med Clin North Am. 2011;95:27–41. [PubMed] [Google Scholar]
14. Hooton TM, Scholes D, Hughes JP, et al. A prospective study of risk factors for symptomatic urinary tract infection in young women. N Engl J Med. 1996;335:468–74. [PubMed] [Google Scholar]
15. Neal DE., Jr Complicated urinary tract infections. Urol Clin North Am. 2008;35:13–22. v. [PubMed] [Google Scholar]
16. Raz R, Gennesin Y, Wasser J, et al. Recurrent urinary tract infections in postmenopausal women. Clin Infect Dis. 2000;30:152–6. [PubMed] [Google Scholar]
17. Hooton TM, Stapleton AE, Roberts PL, et al. Perineal anatomy and urine-voiding characteristics of young women with and without recurrent urinary tract infections. Clin Infect Dis. 1999;29:1600–1. [PubMed] [Google Scholar]
18. Nicolle LE. Uncomplicated urinary tract infection in adults including uncomplicated pyelonephritis. Urol Clin North Am. 2008;35:1–12. v. [PubMed] [Google Scholar]
19. Lawrentschuk N, Ooi J, Pang A, et al. Cystoscopy in women with recurrent urinary tract infection. Int J Urol. 2006;13:350–3. [PubMed] [Google Scholar]
20. Engel G, Schaeffer AJ, Grayhack JT, et al. The role of excretory urography and cystoscopy in the evaluation and management of women with recurrent urinary tract infection. J Urol. 1980;123:190–1. [PubMed] [Google Scholar]
21. Fowler JE, Jr, Pulaski ET. Excretory urography, cystography, and cystoscopy in the evaluation of women with urinary-tract infection: a prospective study. N Engl J Med. 1981;304:462–5. [PubMed] [Google Scholar]
22. van Haarst EP, van Andel G, Heldeweg EA, et al. Evaluation of the diagnostic workup in young women referred for recurrent lower urinary tract infections. Urology. 2001;57:1068–72. [PubMed] [Google Scholar]
23. Mogensen P, Hansen LK. Do intravenous urography and cystoscopy provide important information in otherwise healthy women with recurrent urinary tract infection? Br J Urol. 1983;55:261–3. [PubMed] [Google Scholar]
24. Nickel JC, Wilson J, Morales A, et al. Value of urologic investigation in a targeted group of women with recurrent urinary tract infections. Can J Surg. 1991;34:591–4. [PubMed] [Google Scholar]
25. Wollin T, Laroche B, Psooy K. Canadian guidelines for the management of asymptomatic microscopic hematuria in adults. Can Urol Assoc J. 2009;3:77–80. [PMC free article] [PubMed] [Google Scholar]
26. Aslaksen A, Baerheim A, Hunskaar S, et al. Intravenous urography versus ultrasonography in evaluation of women with recurrent urinary tract infection. Scand J Prim Health Care. 1990;8:85–9. [PubMed] [Google Scholar]
27. Spencer J, Lindsell D, Mastorakou I. Ultrasonography compared with intravenous urography in investigation of urinary tract infection in adults. BMJ. 1990;301:221–4. [PMC free article] [PubMed] [Google Scholar]
28. Andrews SJ, Brooks PT, Hanbury DC, et al. Ultrasonography and abdominal radiography versus intravenous urography in investigation of urinary tract infection in men: prospective incident cohort study. BMJ. 2002;324:454–6. [PMC free article] [PubMed] [Google Scholar]
29. McNicholas MM, Griffin JF, Cantwell DF. Ultrasound of the pelvis and renal tract combined with a plain film of abdomen in young women with urinary tract infection: can it replace intravenous urography? A prospective study. Br J Radiol. 1991;64:221–4. [PubMed] [Google Scholar]
30. Lewis-Jones HG, Lamb GH, Hughes PL. Can ultrasound replace the intravenous urogram in preliminary investigation of renal tract disease? A prospective study. Br J Radiol. 1989;62:977–80. [PubMed] [Google Scholar]
31. Jagjivan B, Moore DJ, Naik DR. Relative merits of ultrasound and intravenous urography in the investigation of the urinary tract. Br J Surg. 1988;75:246–8. [PubMed] [Google Scholar]
32. Kodner CM, Thomas Gupton EK. Recurrent urinary tract infections in women: diagnosis and management. Am Fam Physician. 2010;82:638–43. [PubMed] [Google Scholar]
33. Scholes D, Hooton TM, Roberts PL, et al. Risk factors for recurrent urinary tract infection in young women. J Infect Dis. 2000;182:1177–82. [PubMed] [Google Scholar]
34. Fihn SD, Boyko EJ, Chen CL, et al. Use of spermicide-coated condoms and other risk factors for urinary tract infection caused by Staphylococcus saprophyticus. Arch Intern Med. 1998;158:281–7. [PubMed] [Google Scholar]
35. Handley MA, Reingold AL, Shiboski S, et al. Incidence of acute urinary tract infection in young women and use of male condoms with and without nonoxynol-9 spermi [PubMed] [Google Scholar]
36. Sen A. Recurrent cystitis in non-pregnant women. Clin Evid (Online) 2008;pii:0801. [Google Scholar]
37. Barrons R, Tassone D. Use of Lactobacillus probiotics for bacterial genitourinary infections in women: a review. Clin Ther. 2008;30:453–68. [PubMed] [Google Scholar]
38. Abad CL, Safdar N. The role of lactobacillus probiotics in the treatment or prevention of urogenital infections–a systematic review. J Chemother. 2009;21:243–52. [PubMed] [Google Scholar]
39. Jepson RG, Craig JC. Cranberries for preventing urinary tract infections. Cochrane Database Syst Rev. 2008:CD001321. [PubMed] [Google Scholar]
40. Stothers L. A randomized trial to evaluate effectiveness and cost effectiveness of naturopathic cranberry products as prophylaxis against urinary tract infection in women. Can J Urol. 2002;9:1558–62. [PubMed] [Google Scholar]
41. Kontiokari T, Sundqvist K, Nuutinen M, et al. Randomised trial of cranberry-lingonberry juice and Lactobacillus GG drink for the prevention of urinary tract infections in women. BMJ. 2001;322:1571. [PMC free article] [PubMed] [Google Scholar]
42. Barbosa-Cesnik C, Brown MB, Buxton M, et al. Cranberry juice fails to prevent recurrent urinary tract infection: results from a randomized placebo-controlled trial. Clin Infect Dis. 2011;52:23–30. [PMC free article] [PubMed] [Google Scholar]
43. Albert X, Huertas I, Pereiró II, et al. Antibiotics for preventing recurrent urinary tract infection in non-pregnant women. Cochrane Database Syst Rev. 2004:CD001209. [PMC free article] [PubMed] [Google Scholar]
44. Cetti RJ, Venn S, Woodhouse CR. The risks of long-term nitrofurantoin prophylaxis in patients with recurrent urinary tract infection: a recent medico-legal case. BJU Int. 2009;103:567–9. [PubMed] [Google Scholar]
45. Stamm WE, Counts GW, Wagner KF, et al. Antimicrobial prophylaxis of recurrent urinary tract infections: a double-blind, placebo-controlled trial. Ann Intern Med. 1980;92:770–5. [PubMed] [Google Scholar]
46. Pfau A, Sacks T, Engelstein D. Recurrent urinary tract infections in premenopausal women: prophylaxis based on an understanding of the pathogenesis. J Urol. 1983;129:1153–7. [PubMed] [Google Scholar]
47. Brumfitt W, Smith GW, Hamilton-Miller JM, et al. A clinical comparison between Macrodantin and trimethoprim for prophylaxis in women with recurrent urinary infections. J Antimicrob Chemother. 1985;16:111–20. [PubMed] [Google Scholar]
48. Melekos MD, Asbach HW, Gerharz E, et al. Post-intercourse versus daily ciprofloxacin prophylaxis for recurrent urinary tract infections in premenopausal women. J Urol. 1997;157:935–9. [PubMed] [Google Scholar]
49. Martinez FC, Kindrachuk RW, Thomas E, et al. Effect of prophylactic, low dose cephalexin on fecal and vagin*l bacteria. J Urol. 1985;133:994–6. [PubMed] [Google Scholar]
50. Pfau A, Sacks TG. Effective prophylaxis of recurrent urinary tract infections in premenopausal women by postcoital administration of cephalexin. J Urol. 1989;142:1276–8. [PubMed] [Google Scholar]
51. Brumfitt W, Hamilton-Miller JM. A comparative trial of low dose cefaclor and macrocrystalline nitrofurantoin in the prevention of recurrent urinary tract infection. Infection. 1995;23:98–102. [PubMed] [Google Scholar]
52. Bailey RR, Roberts AP, Gower PE, et al. Prevention of urinary-tract infection with low-dose nitrofurantoin. Lancet. 1971;2:1112–4. [PubMed] [Google Scholar]
53. Raz R, Boger S. Long-term prophylaxis with norfloxacin versus nitrofurantoin in women with recurrent urinary tract infection. Antimicrob Agents Chemother. 1991;35:1241–2. [PMC free article] [PubMed] [Google Scholar]
54. Nicolle LE, Harding GK, Thompson M, et al. Prospective, randomized, placebo-controlled trial of norfloxacin for the prophylaxis of recurrent urinary tract infection in women. Antimicrob Agents Chemother. 1989;33:1032–5. [PMC free article] [PubMed] [Google Scholar]
55. Rudenko N, Dorofeyev A. Prevention of recurrent lower urinary tract infections by long-term administration of fosfomycin trometamol. Double blind, randomized, parallel group, placebo controlled study. Arzneimittelforschung. 2005;55:420–7. [PubMed] [Google Scholar]
56. Pfau A, Sacks TG. Effective postcoital quinolone prophylaxis of recurrent urinary tract infections in women. J Urol. 1994;152:136–8. [PubMed] [Google Scholar]
57. Nicolle LE, Harding GK, Thomson M, et al. Efficacy of five years of continuous, low-dose trimethoprim-sulfamethoxazole prophylaxis for urinary tract infection. J Infect Dis. 1988;157:1239–42. [PubMed] [Google Scholar]
58. Stapleton A, Latham RH, Johnson C, et al. Postcoital antimicrobial prophylaxis for recurrent urinary tract infection. A randomized, double-blind, placebo-controlled trial. JAMA. 1990;264:703–6. [PubMed] [Google Scholar]
59. Schaeffer AJ, Stuppy BA. Efficacy and safety of self-start therapy in women with recurrent urinary tract infections. J Urol. 1999;161:207–11. [PubMed] [Google Scholar]
60. Gupta K, Hooton TM, Roberts PL, et al. Patient-initiated treatment of uncomplicated recurrent urinary tract infections in young women. Ann Intern Med. 2001;135:9–16. [PubMed] [Google Scholar]
61. Wong ES, McKevitt M, Running K, et al. Management of recurrent urinary tract infections with patient-administered single-dose therapy. Ann Intern Med. 1985;102:302–7. [PubMed] [Google Scholar]
62. Perrotta C, Aznar M, Mejia R, et al. Oestrogens for preventing recurrent urinary tract infection in post-menopausal women. Cochrane Database Syst Rev. 2008:CD005131. [PubMed] [Google Scholar]
63. Raz R, Stamm WE. A controlled trial of intravagin*l estriol in postmenopausal women with recurrent urinary tract infections. N Engl J Med. 1993;329:753–6. [PubMed] [Google Scholar]
64. Eriksen B. A randomized, open, parallel-group study on the preventive effect of an estradiol-releasing vagin*l ring (Estring) on recurrent urinary tract infections in postmenopausal women. Am J Obstet Gynecol. 1999;180:1072–9. [PubMed] [Google Scholar]
65. Society of Obstetricians and Gynaecologists of Canada SOGC clinical practice guidelines. The detection and management of vagin*l atrophy. Int J Gynaec ol Obstet. 2004;88:222–8. [PubMed] [Google Scholar]
